10X Genomics Stock
Innovative Genomics Platform
Sign up today and learn more about 10X Genomics Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About 10X Genomics Stock
10x Genomics is creating revolutionary DNA sequencing technology to help researchers better identify subtle variations that are overlooked by technologies that shred biological samples into tiny fragments before sequencing the short stretches and using computers to assembling them into a genome.
Investors
Meritech Capital Partners
UiPath, DataRobot, FTX Exchange, Cloudera, Alto Pharmacy, Box, Domo, Outreach, Lime, MuleSoft
Venrock
Devoted Health, Zenefits, TAE Technologies, Dollar Shave Club, Lucid Motors, Dataminr, 6sense, AppNexus, Salsify, Astranis
Funding History
| October 2012 | $3.0M |
|---|---|
| January 2015 | $55.0M |
| March 2016 | $55.0M |
| April 2018 | $50.0M |
| April 2018 | $75.0M |
Management
Co-founder & CEO
Serge Saxonov
Chief Scientific Officer, President, Co-founder
Ben Hindson
Chief Commercial Officer
Brad Crutchfield
Press
TechCrunch - Jan, 8 2021
Venrock’s Bryan Roberts on the firm’s new $450 million fund, and where it’s shopping in 2021Forbes - Dec, 5 2019
Why 10X Genomics Has Rallied Post Its IPOTechnology Networks - Jun, 23 2018
10x Genomics Extends their Application Portfoliohcanews.com - May, 1 2018
With $125M Windfall, 10x Genomics Continues Gold RushGenomeWeb - Apr, 13 2018
New Products Posted to GenomeWeb: Qiagen, Fluidigm, 10x Genomics, MoreEquityZen Recognized As:
